Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $8.5 million.

  • Milestone Scientific's Liabilities and Shareholders Equity fell 2406.19% to $8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.4 million, marking a year-over-year decrease of 2283.21%. This contributed to the annual value of $9.8 million for FY2024, which is 1384.55% down from last year.
  • As of Q3 2025, Milestone Scientific's Liabilities and Shareholders Equity stood at $8.5 million, which was down 2406.19% from $8.1 million recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Liabilities and Shareholders Equity peaked at $22.6 million during Q1 2021, and registered a low of $8.1 million during Q2 2025.
  • In the last 5 years, Milestone Scientific's Liabilities and Shareholders Equity had a median value of $12.0 million in 2024 and averaged $13.8 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 25517.57% in 2021, then plummeted by 3562.42% in 2023.
  • Milestone Scientific's Liabilities and Shareholders Equity (Quarter) stood at $19.8 million in 2021, then tumbled by 30.83% to $13.7 million in 2022, then decreased by 17.01% to $11.4 million in 2023, then fell by 13.85% to $9.8 million in 2024, then decreased by 13.38% to $8.5 million in 2025.
  • Its Liabilities and Shareholders Equity was $8.5 million in Q3 2025, compared to $8.1 million in Q2 2025 and $9.1 million in Q1 2025.